In vitro antimicrobial efficacy of β‐defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin

β‐Defensins (BDs) are highly conserved antimicrobial peptides important in innate defence against bacteria. β‐Defensin 3 has a specific role in protecting the skin. This study quantified the minimal inhibitory concentration (MIC) of human (h)BD3 against Staphylococcus pseudintermedius isolates from atopic and healthy dogs. Single colony isolates (1 × 10⁵ colony‐forming units/mL log phase) were cultured with doubling dilutions of hBD3 in sodium phosphate buffer from 0.8 to 50 μg/mL at 37 °C for 2 h, before adding 100 μL of tryptone soy broth and incubating for a further 20 h. Bacterial growth was assessed as the mean optical density at 540 nm corrected for background. The median MIC was 12.5 μg hBD3/mL (range 3.125–25 μg/mL; n = 22). Forty‐five percent of the isolates were inhibited at ≤6.25 μg hBD3/mL, and 90% were inhibited at ≤12.5 μg hBD3/mL. Bacterial growth was not inhibited at ≤1.6 μg hBD3/mL. There were no significant differences in the inhibition by hBD3 of isolates from atopic (median MIC 12.5 μg/mL, range 6.25–25 μg/mL, n = 14) and healthy dogs (median MIC 9.4 μg/mL, range 3.125–12.5 μg/mL, n = 8); from noninfected colonized sites (median MIC 12.5 μg/mL, range 3.125–25 μg/mL, n = 16) and infected lesions (median MIC 9.4 μg/mL, range 6.25–12.5 μg/mL, n = 6); or between sample sites (nose median MIC 12.5 μg/mL, range 6.25–25 μg/mL, n = 5; perineum median MIC 12.5 μg/mL, range 3.125–25 μg/mL, n = 7; ear median MIC 6.25 μg/mL, range 6.25–12.5 μg/mL, n = 4; lesions median MIC 9.4 μg/mL, range 6.25–12.5 μg/mL, n = 6). In conclusion, hBD3 inhibited the growth of canine S. pseudintermedius isolates in vitro irrespective of origin.     

In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates

Background – Meticillin‐resistant Staphylococcus aureus (MRSA) and meticillin‐resistant Staphylococcus pseudintermedius (MRSP) infections are increasingly reported in dogs, and these bacteria may be isolated from ear infections. Hypothesis/Objectives – The main aim of the present study was to investigate the in vitro antimicrobial activity of miconazole, polymyxin B and a combination of both against 24 canine MRSA and 50 canine MRSP isolates. The minimal inhibitory concentration (MIC) values of 12 other antimicrobial agents were also determined. Methods – All MIC values were determined according to a broth microdilution assay. Results – Acquired resistance was found to all tested agents, except for linezolid, miconazole and polymyxin B. The MIC values for miconazole and polymyxin B against MRSA were in the range of 4–8 and 8–64 μg/mL, respectively, while the MIC values for miconazole and polymyxin B against MRSP were in the range of 1–2 and 0.25–4 μg/mL, respectively. Using a combination of miconazole and polymyxin B, there was no evidence for enhanced in vitro activity of the combination (i.e. synergy) of both products. Nevertheless, MIC₉₀ values of the combination of these antimicrobial agents and of a commercial product containing both agents were at least 1000 times lower than the concentration present in the commercial product. Conclusions and clinical importance – These results indicate that the topical use of a combination of miconazole and polymyxin B in a 43.5:1 ratio may have potential for the treatment of MRSA‐mediated and MRSP‐associated otitis externa in dogs.     

Molecular heterogeneity in clinical isolates of Malassezia pachydermatis from dogs

Molecular investigation of 16 strains, conventionally identified to be Malassezia pachydermatis, isolated from dogs in Japan was carried out by random amplification of polymorphic DNA (RAPD) and chitin synthase 2 (CHS2) gene sequence analyses. The RAPD band patterns of 13 clinical isolates were identical to that of standard strain of M. pachydermatis (CBS-1879). The other three clinical isolates were different from the standard strain of M. pachydermatis in RAPD patterns, and two of the three isolates were identical. About 620 bp genomic DNA fragments of the CHS2 gene were amplified from the same 16 clinical isolates of M. pachydermatis by polymerase chain reaction (PCR) and sequenced. The phylogenetic analysis of the nucleotide sequences of CHS2 gene fragments of the 16 clinical isolates revealed that the 13 strains were genetically very close to the standard strain of M. pachydermatis and the other two isolates were genetically close to the standard strain of M. furfur rather than M. pachydermatis. The remaining one isolate was phylogenetically distinct from all the seven Malassezia species reported so far.     

Factors affecting the adherence of Malassezia pachydermatis to canine corneocytes in vitro

Abstract Suspensions of Malassezia pachydermatis adhered to canine corneocytes attached io adhesive tape in a dose (P < 0.001) and time-dependent (P < 0.01) manner; adherence was maximal after 2 h. M. pachydermatis cells were approximately 10 times more adherent than Saccharomyces cerevisiae (P < 0.001) cells after 2 h incubation. The adherence of formalin-treated and frozen-thawed M. pachydermatis cells was comparable with untreated controls. Stationary-phase cells adhered better (P < 0.05) than exponential-phase cells. Pretreatment of the yeasts, or corneocytes, with 0.1% trypsin for 30 min reduced (P < 0.01) the adherence of four, and two, out of five strains, respectively, whereas incubation with 300 mM solutions of D(+) mannose, sucrose and N-acetyl D-glucosamine had no consistent effect. These results suggest that trypsin-sensitive proteins or glycoproteins on the yeast cell wall, and on the corneocyte surface, play an important role in the adherence of M. pachydermatis to canine corneocytes in vitro, whereas a role for carbohydrate receptors was not demonstrated. Résumé— Des suspensions de Malassezia pachydermatis adhérant à des cornéocytes des chiens sont attachées à des rubans adhésifs de façon significative en function du nombre (P < 0,001) et de la durée (P < 0,01). L'adhérence est maximale après 2 heures. Les levures du genre Malassezia pachydermatis sont approximativement dix fois plus adhérentes que les levures du genre Saccharomyces cerevisiae (P < 0,001) après une incubation de 2 heures. L'adhérence des Malassezia pachydermatis traitées par le formol et congelées - décongelées, est comparable à celle des témoins. Les levures qui ne sont pas en phase de croissance adhérent mieux (P < 0,05) que celles qui le sont. Le traitement préalable des levures ou des cornéocytes avec une solution de trypsine pendant 30 minutes réduit (P < 0,01) l'adhérence tandis que l'incubation avec des solutions à 300 mM de D + mannose, sucrose et de N acétyl D glucosamine n'a pas d'effets. Ces résultats suggèrent que des protéines sensibles à la trypsine ou des glycoprotéines sur la paroi des levures et à la surface des cornéocytes jouent un rôle important in vitro dans l'adhérence des Malassezia pachydermatis aux cornéocytes du chien, alors que le rôle des récepteurs glucidiques n'a pas été démontré. [Bond, R., Lloyd, D. H. Factors affecting the adherence of Malassezia pachydermatis to canine cornéocytes in vitro (Facteurs influençant l'adhérence de Malassezia pachydermatis aux cornéocytes du chien in vitro). Veterinary Dermatology 1996; 7 : 49–56.] Resumen Las suspensiones de Malassezia pachydermatis se adherian a cinta adhesiva de forma dependiente de la dosis (P < 0.001) y del tiempo (P < 0.01); su adherencia fue máxima a las 2 h. Las células de M. pachydermatis fueron aproximadamente 10 veces más adherentes que las de Saccharomyces cerevisiae (P < 0.001) a las 2 h de incubación. La adherencia de células de M. pachydermatis tratadas con formalina y congeladas-descongeladas fue comparable con los controles no tratados. Las células en estadio estacionario se adherian mejor (P < 0.05) que las de fase exponencial. El tratamiento previo de las levaduras o los corneocitos con 0.1% de tripsina durante 30 min redujo (P < 0.01) la adherencia de cuatro, y dos, de cinco cepas, respectivamente, mientras que su incubación con soluciones 300 mM de D(+) manosa, sucrosa y N-acetil D-glucosamina no tuvieron un efecto constante. Estos resultados sugieren que proteinas o glieoproteinas sensibles a la tripsina en la pared de la levadura, y en la superficie del corneocito, juegan un papel importante en la adherencia de M. pachydermatis a los corneocitos caninos in vitro, mientras que no se pudo demostrar un papel por parte de los receptores de carbohidratos. [Bond, R., Lloyd, D. H. Factors affecting the adherence of Malassezia pachydermatis to canine corneocytes in vitro (Facto res que afectan la adherencia de Malassezia pachydermatis a los corneocitos caninos in vitro). Veterinary Dermatology 1996; 7 : 49–56.] Zusammenfassung— Suspensionen von Malassezia pachydermatis zeigten eine Adhärenz an kanine Korneozyten, die an einem Klebeband befestigt waren, in dosisabhängiger (P < 0,001) und zeitabhängiger Weise (P < 0,01). Die Adhärenz erreichte ein maximum nach 2 Stunden. M. pachydermatis-Zellen waren ungefähr 10 mal stärker adhärent als Saccharomyces cervisiae-Zellen nach Zstündiger Inkubation (P < 0,001). Die Adhärenz von formalinbehandelten und gefrorenen/aufgetauten M. pachydermatis-Zellen war vergleichbar mit unbehandelten Kontrollzellen. Zellen der stationären Phase waren besser adhärent (P < 0,05) als Zellen der exponentiellen Phase. Eine Vorbehandlung der Hefen oder Korneozyten mit 0,1% igem Trypsin über 30 Minuten reduzierte die Adhärenz (P < 0,01) von 4 bzw. 2 aus 5 Linien, während eine Inkubation mit 300 mm Lösungen von D(+)Mannose, Sucrose und N-Acetyl-D-Glukosaminen keinen entsprechenden Effekt hatte. Diese Ergebnisse legen nahe, daß Trypsin-sensible Proteine oder Glykoproteine an der Zellwand der Hefe und auf der Korneozytenoberfläche eine wichtige Rolle für die Adhärenz von M. pachydermatis an kanine Korneozyten in-vitro spielen, während eine Bedeutung für Kohlenhydrat-Rezeptoren nicht demonstriert werden konnte. [Bond, R., Lloyd, D. H. Factors affecting the adherence of Malassezia pachydermatis to canine corneocytes in vitro (Einflußfaktoren auf die Adhärenz von Malassezia pachydermatis an kanine Korneozyten in vitro). Veterinary Dermatology 1996; 7 : 49–56.]     

In vitro miconazole susceptibility of meticillin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus

Background – The emergence and dissemination of meticillin‐resistant staphylococci has created significant treatment challenges in veterinary medicine and increased interest in topical therapy for superficial infections. Concern has been expressed regarding the use of some topical antimicrobials in animals because of the potential for emergence of resistance, and additional options are required. Miconazole has limited antibacterial properties that include antistaphylococcal activity. Hypothesis/Objectives – The objective of this study was to assess the in vitro susceptibility of Staphylococcus pseudintermedius and Staphylococcus aureus to miconazole. Methods – In vitro susceptibility of 112 meticillin‐resistant S. pseudintermedius (MRSP), 53 meticillin‐resistant S. aureus (MRSA) and 37 meticillin‐susceptible S. pseudintermedius (MSSP) to miconazole was assessed using agar dilution. Results – The minimal inhibitory concentration (MIC) range, MIC₅₀ and MIC₉₀ for MRSP were 1–8, 2 and 4 μg/mL, respectively. Corresponding results for MRSA were 1–8, 2 and 6 μg/mL, and for MSSP 1–4, 2 and 2 μg/mL. The MIC for MSSP was a significantly lower MIC than that for both MRSP (P = 0.006) and MRSA (P < 0.001), while the MIC for MRSP was significantly lower than that for MRSA (P = 0.001). Conclusions and clinical importance – These in vitro data suggest that miconazole could be a useful therapeutic option for superficial infections caused by meticillin‐susceptible and meticillin‐resistant staphylococci, but proper clinical investigation is required.